The prognostic potential of alternative transcript isoforms across human tumors

[1]  J. Valcárcel,et al.  Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks , 2016, Genome research.

[2]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[3]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[4]  Charlotte Soneson,et al.  A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome , 2015, Clinical Cancer Research.

[5]  Scott D. Findlay,et al.  Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles , 2015, Breast Cancer Research.

[6]  R. Verhaak,et al.  Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm , 2015, Scientific Reports.

[7]  Amit Verma,et al.  Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma. , 2015, Molecular cell.

[8]  C. Koh,et al.  MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis , 2015, Nature.

[9]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[10]  Mark A. Ragan,et al.  Breast cancer classification: linking molecular mechanisms to disease prognosis , 2015, Briefings Bioinform..

[11]  M. Ragan,et al.  An evaluation of DNA-damage response and cell-cycle pathways for breast cancer classification , 2015, 1505.04846.

[12]  Mark A. Rubin,et al.  Health: Make precision medicine work for cancer care , 2015, Nature.

[13]  S. Aerts,et al.  Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells , 2015, eLife.

[14]  I. Holen,et al.  Molecular alterations that drive breast cancer metastasis to bone. , 2015, BoneKEy reports.

[15]  G. McArthur,et al.  Phenotype Switching in Melanoma: Implications for Progression and Therapy , 2015, Front. Oncol..

[16]  Eduardo Eyras,et al.  Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer , 2015, Nucleic acids research.

[17]  Jun Yokota,et al.  The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[18]  G. Prendergast,et al.  IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. , 2014, International immunology.

[19]  C. Ballaré,et al.  Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells , 2014, Proceedings of the National Academy of Sciences.

[20]  K. Baggerly,et al.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. , 2014, Cancer cell.

[21]  Rob Patro,et al.  Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms , 2013, Nature Biotechnology.

[22]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[23]  J. Harrow,et al.  Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene , 2013, Genome Biology.

[24]  E. Pilozzi,et al.  Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway , 2013, Oncogene.

[25]  Florian Markowetz,et al.  Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions , 2013, Nature Medicine.

[26]  Lewis C Cantley,et al.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy , 2013, Nature Medicine.

[27]  B. Bernstein,et al.  Epigenetic Reprogramming in Cancer , 2013, Science.

[28]  Alan Bridge,et al.  New and continuing developments at PROSITE , 2012, Nucleic Acids Res..

[29]  Robert Patro,et al.  Sailfish: Alignment-free Isoform Quantification from RNA-seq Reads using Lightweight Algorithms , 2013, ArXiv.

[30]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[31]  R. Gillies,et al.  Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.

[32]  T. Hudson,et al.  The Genetic Basis for Cancer Treatment Decisions , 2012, Cell.

[33]  C. Brennan,et al.  Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas , 2011, The EMBO journal.

[34]  Karine Tremblay,et al.  Alternative splicing of SYK regulates mitosis and cell survival , 2011, Nature Structural &Molecular Biology.

[35]  B. Spencer‐Dene,et al.  FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation , 2011, The Journal of experimental medicine.

[36]  K. Hoek,et al.  Cancer stem cells versus phenotype‐switching in melanoma , 2010, Pigment cell & melanoma research.

[37]  Sherif Abou Elela,et al.  Cancer-associated regulation of alternative splicing , 2009, Nature Structural &Molecular Biology.

[38]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[40]  U. Philippar,et al.  Human Mena+11a Isoform Serves as a Marker of Epithelial Phenotype and Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Pancreatic Cancer Cell Lines , 2008, Clinical Cancer Research.

[41]  C. Chiaverini,et al.  Microphthalmia-associated Transcription Factor Regulates RAB27A Gene Expression and Controls Melanosome Transport* , 2008, Journal of Biological Chemistry.

[42]  R. Dummer,et al.  In vivo switching of human melanoma cells between proliferative and invasive states. , 2008, Cancer research.

[43]  I. Ellis,et al.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer , 2007, Genome Biology.

[44]  I. Yang,et al.  Molecular staging for survival prediction of colorectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  H. Handa,et al.  The Pax6 isoform bearing an alternative spliced exon promotes the development of the neural retinal structure. , 2005, Human molecular genetics.

[46]  Eibe Frank,et al.  Logistic Model Trees , 2003, Machine Learning.

[47]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[48]  L. Sobin,et al.  TNM: evolution and relation to other prognostic factors. , 2003, Seminars in surgical oncology.

[49]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[50]  Mark A. Hall,et al.  Correlation-based Feature Selection for Discrete and Numeric Class Machine Learning , 1999, ICML.

[51]  Usama M. Fayyad,et al.  Multi-Interval Discretization of Continuous-Valued Attributes for Classification Learning , 1993, IJCAI.

[52]  D.,et al.  Regression Models and Life-Tables , 2022 .